France· FR:68544663
EMBLAVEO 1,5 g/0,5 g, poudre pour solution à diluer pour perfusion
A medicinal product containing avibactam sodique + aztréonam, registered in France by PFIZER EUROPE MA EEIG (BELGIQUE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- AVIBACTAM SODIQUE + AZTRÉONAM
- Manufacturer
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340093029343010 flacon(s) en verre de 30 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Avibactam sodique + aztréonam in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesEMBLAVEOAbbVie Inc.
- SpainEMBLAVEO 1,5 G/0,5 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONPfizer Europe Ma Eeig
- FinlandEmblaveoPfizer Europe MA EEIG
- United KingdomEmblaveo 1.5g/0.5g powder for concentrate for solution for infusion vialsPfizer Ltd
- IrelandEmblaveo 1.5 g/0.5 g powder for concentrate for solution for infusionPfizer Europe MA EEIG
- CzechiaEMBLAVEOPfizer Europe MA EEIG, Bruxelles
- NorwayEmblaveoPfizer Europe MA EEIG
- PolandEmblaveoPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Emblaveo
- Liechtenstein · Emblaveo
- Norway · Emblaveo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8b49567b-f6b9-4d10-bc6b-cd39bc5dd8bd GET /v1/drugs/8b49567b-f6b9-4d10-bc6b-cd39bc5dd8bd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68544663",
"date_amm": "2024-04-22",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/24/1808",
"substance": "AVIBACTAM SODIQUE + AZTRÉONAM",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about avibactam sodique + aztréonam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.